Arcus Biosciences (RCUS) Non Operating Interest Expenses (2023 - 2026)
Arcus Biosciences (RCUS) reported Non Operating Interest Expenses of $3 million for Q2 2026, up 50.0% from $2 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Non Operating Interest Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arcus Biosciences' Non Operating Interest Expenses came in at $11 million, up 83.3% year-over-year; for FY2025, it was $8 million, up 100.0% from FY2024.
- Non Operating Interest Expenses has a three-year compound annual growth rate of 58.7% (FY2022 to FY2025).
- By year, Non Operating Interest Expenses came in at $4 million in FY2024 (+100.0%), $2 million in FY2023 (unchanged) and $2 million in FY2022.
- Year over year, Non Operating Interest Expenses gained in three of the last six quarters, with growth averaging 75.0%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $3 million (Q1 2026), $2 million (Q4 2025) and $3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arcus Biosciences | 3.28 Bn | -53.05 Mn | - | 3.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Sep 30, 2023 | 1.00 Mn |
API Access
Arcus Biosciences Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();